Company intelligence / Profile preview
Apollo Therapeutics
Cambridge, UKapollotherapeutics.com ↗
- Ownership
- Private
- Employees
- ~60
- Development stage
- Other
01
Overview
Apollo Therapeutics is developing a portfolio of novel therapeutics with six programs in development and over 15 more in discovery and preclinical development
- Therapeutic areas
- OncologyImmunologyRare Diseases
- Modalities
- Small moleculesmonoclonal antibodies
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
03
Partnerships
University of CambridgeUCLImperial College LondonKings College LondonInstitute of Cancer ResearchAstraZenecaGSKJohnson & Johnson Innovation
Beyond the preview
Go deeper on Apollo Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Apollo Therapeutics.